Avidity Biosciences, Inc. (RNA)

Avidity Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	219.87	185.08	340.4	320.45	321.46
Short-Term Investments	1,282	410.27	270.33	85.1	6.68
Cash & Short-Term Investments	1,501	595.35	610.73	405.54	328.14
Cash Growth	152.20%	-2.52%	50.59%	23.59%	246.95%
Accounts Receivable	-	1.11	2.36	0.9	1.2
Other Receivables	28.22	7.52	1.51	-	-
Receivables	28.22	8.62	3.88	0.9	1.2
Prepaid Expenses	12.57	7.33	8.34	4.7	2.34
Total Current Assets	1,542	611.31	622.94	411.14	331.68
Property, Plant & Equipment	18.29	16.65	15.01	15.59	1.92
Other Long-Term Assets	3.32	0.6	0.85	0.85	0.3
Total Assets	1,564	628.56	638.8	427.58	333.9
Accounts Payable	8.46	8.81	4.64	2.81	7.75
Accrued Expenses	64.73	39.87	39.13	20.22	3.15
Current Portion of Leases	3.84	3.64	3.11	1.77	-
Current Unearned Revenue	20.99	28.37	5.04	4.86	3.69
Total Current Liabilities	98.02	80.68	51.91	29.66	14.59
Long-Term Leases	2.96	6.21	7.58	9.96	0.94
Long-Term Unearned Revenue	37.96	40.9	1.24	6.53	12.15
Total Liabilities	138.94	127.79	60.73	46.15	27.68
Common Stock	0.01	0.01	0.01	0.01	0
Additional Paid-In Capital	2,315	1,071	939.31	566.16	372.76
Retained Earnings	-893.07	-570.76	-358.54	-184.55	-66.54
Comprehensive Income & Other	2.9	0.13	-2.7	-0.19	-0.01
Total Common Equity	1,425	500.76	578.08	381.43	306.22
Shareholders' Equity	1,425	500.76	578.08	381.43	306.22
Total Liabilities & Equity	1,564	628.56	638.8	427.58	333.9
Total Debt	6.8	9.85	10.69	11.73	0.94
Net Cash (Debt)	1,495	585.5	600.04	393.81	327.2
Net Cash Growth	155.29%	-2.42%	52.37%	20.36%	265.01%
Net Cash Per Share	13.40	8.02	11.50	9.51	15.10
Filing Date Shares Outstanding	120.21	79.72	70.81	47.75	37.58
Total Common Shares Outstanding	119.89	79.28	69.77	47.75	37.57
Working Capital	1,444	530.63	571.03	381.48	317.09
Book Value Per Share	11.89	6.32	8.29	7.99	8.15
Tangible Book Value	1,425	500.76	578.08	381.43	306.22
Tangible Book Value Per Share	11.89	6.32	8.29	7.99	8.15
Machinery	16.42	13.31	9.13	6.29	3.03
Construction In Progress	3.96	-	-	-	-
Leasehold Improvements	0.29	0.29	0.25	0.25	0.42

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q